2023
TCT-627 Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data
Snyder D, Zilinyi R, Pruthi S, George S, Tirziu D, Lansky A, Mintz A, Sethi S, Parikh S. TCT-627 Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data. Journal Of The American College Of Cardiology 2023, 82: b252-b253. DOI: 10.1016/j.jacc.2023.09.638.Peer-Reviewed Original Research
2022
Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease
Binyamin G, Gaston S, Konstantino E, Konstantino M, Lansky A. Chapter 30 The “nitinol-constrained” Chocolate balloon angioplasty: clinical applications in patients with severe atherosclerotic peripheral arterial disease. 2022, 673-688. DOI: 10.1016/b978-0-12-821451-0.00006-9.Peer-Reviewed Original ResearchPeripheral arterial diseaseAtherosclerotic peripheral arterial diseaseArterial diseaseBalloon angioplastyRevascularization strategyImpaired perfusionClinical syndromeBalloon catheterInvasive treatmentAngioplastyAngioplasty devicesDiseaseClinical applicationStentingPatientsCatheterSyndromePerfusionMainstay
2019
Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System 12-Month Results From the TOBA II Study
Gray WA, Cardenas JA, Brodmann M, Werner M, Bernardo NI, George JC, Lansky A. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System 12-Month Results From the TOBA II Study. JACC Cardiovascular Interventions 2019, 12: 2375-2384. PMID: 31806218, DOI: 10.1016/j.jcin.2019.08.005.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, BalloonBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationEuropeFemaleFemoral ArteryHumansMaleMiddle AgedPeripheral Arterial DiseasePopliteal ArteryProspective StudiesProsthesis DesignRisk FactorsStentsTime FactorsTreatment OutcomeUnited StatesVascular Access DevicesVascular PatencyVascular System InjuriesConceptsProximal popliteal arteryDrug-coated balloonsSuperficial femoral arteryPlain balloonPopliteal arteryFemoral arteryTack Endovascular SystemLong-term outcomesDCB angioplastyEfficacy endpointPrimary patencyResidual stenosisRestenotic lesionsMulticenter studyFemoropopliteal arteriesEndovascular SystemAngioplastyArteryClassification 2DissectionLesionsBalloonStenosisPatencyPatients
2010
Response to Letter Regarding Article, “Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery
Laird J, Katzen B, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins T, Goldstein J, Jaff M. Response to Letter Regarding Article, “Nitinol Stent Implantation Versus Balloon Angioplasty for Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery. Circulation Cardiovascular Interventions 2010, 3: e23. DOI: 10.1161/circinterventions.110.958181.Peer-Reviewed Original ResearchIMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL
Witzenbichler B, Woehrle J, Guagliumi G, Peruga J, Brodie B, Dudek D, Kornowski R, Hartmann F, Parise H, Lansky A, Nikolsky E, Mehran R, Stone G. IMPACT OF PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION UNDERGOING PRIMARY ANGIOPLASTY: ANALYSIS FROM THE HORIZONS AMI TRIAL. Journal Of The American College Of Cardiology 2010, 55: a182.e1708. DOI: 10.1016/s0735-1097(10)61709-3.Peer-Reviewed Original Research
2005
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)
Stuckey TD, Stone GW, Cox DA, Tcheng JE, Garcia E, Carroll J, Guagliumi G, Rutherford BD, Griffin JJ, Turco M, Lansky AJ, Mehran R, Fahy M, Brodie BR, Grines CL, Investigators F. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). The American Journal Of Cardiology 2005, 95: 1-7. PMID: 15619385, DOI: 10.1016/j.amjcard.2004.08.054.Peer-Reviewed Original ResearchConceptsTarget vessel revascularizationAcute myocardial infarctionPrimary end pointDiabetic patientsNondiabetic patientsPrimary angioplastyDiabetes mellitusStent implantationMyocardial infarctionIschemic target vessel revascularizationEnd pointRoutine stent implantationAbciximab useComposite incidenceReperfusion modalityRoutine stentingAngiographic restenosisVessel revascularizationBalloon angioplastyImproved outcomesPatientsAngioplastyAbciximabDiabetesBeneficial effects
2004
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction
Kandzari DE, Tcheng JE, Grines CL, Cox DA, Stuckey T, Griffin JJ, Turco M, Garcia E, Carroll JD, Fahy M, Lansky AJ, Mehran R, Stone GW, Investigators C. Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction. The American Journal Of Cardiology 2004, 94: 1029-1033. PMID: 15476618, DOI: 10.1016/j.amjcard.2004.06.060.Peer-Reviewed Original ResearchConceptsAcute myocardial infarctionAspirin useMyocardial infarctionPrimary percutaneous coronary interventionInfluence of admissionPrimary coronary angioplastyProspective multicenter trialPercutaneous coronary interventionTime of admissionCoronary interventionCoronary angioplastyMulticenter trialInfarctionAdmissionAngioplastyPatientsTrialsPrognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarctionThe controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial
MCLAUGHLIN M, STONE G, AYMONG E, GARDNER G, MEHRAN R, LANSKY A, GRINES C, TCHENG J, COX D, STUCKEY T. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarctionThe controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. Journal Of The American College Of Cardiology 2004, 44: 1215-1223. DOI: 10.1016/s0735-1097(04)01330-0.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, Balloon, CoronaryCoronary AngiographyCoronary CirculationElectrocardiographyFemaleHeart Conduction SystemHumansMaleMiddle AgedMultivariate AnalysisMyocardial InfarctionPostoperative ComplicationsPredictive Value of TestsPrognosisProspective StudiesRecurrenceRisk FactorsStatistics as TopicSurvival AnalysisTreatment OutcomeMagnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)
Sadeghi HM, Grines CL, Chandra HR, Mehran R, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Lansky AJ, O'Neill WW, Stone GW. Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial). The American Journal Of Cardiology 2004, 94: 637-640. PMID: 15342297, DOI: 10.1016/j.amjcard.2004.05.030.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionAcute myocardial infarctionMyocardial infarctionOutcomes of patientsCADILLAC trialPrimary angioplastyCoronary interventionProcedural successTreatment delayMyocardial recoveryPatientsModest delayInfarctionWeeknightsHoursTreatment timeAngioplastyWeekendsTrials801-3 Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial
Nikolsky E, Halkin A, Aymong E, Mehran R, Lansky A, Grines C, Turco M, Cox D, Garcia E, Tcheng J, Griffin J, Guagliumi G, Stuckey T, Cohen D, Rutherford B, Stone G. 801-3 Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial. Journal Of The American College Of Cardiology 2004, 43: a267. DOI: 10.1016/s0735-1097(04)91134-5.Peer-Reviewed Original Research829-5 Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial
Stone G, Webb J, Cox D, Brodie B, Qureshi M, Dulas D, Kalynych A, Turco M, Schultheiss H, Rutherford B, Kruckoff M, Gibbons R, Lansky A, Pop R, Mehran R, Jones D. 829-5 Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial. Journal Of The American College Of Cardiology 2004, 43: a285-a286. DOI: 10.1016/s0735-1097(04)91210-7.Peer-Reviewed Original Research
2003
Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis
Kobayashi Y, Mehran R, Mintz GS, Dangas G, Moussa I, Collins M, Brara P, Moussavian M, Lansky AJ, Stone GW, Leon MB, Moses JW, Teirstein PS. Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. The American Journal Of Cardiology 2003, 92: 1329-1331. PMID: 14636914, DOI: 10.1016/j.amjcard.2003.08.018.Peer-Reviewed Original ResearchOutcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)
Ashby DT, Aymong EA, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Carroll JD, Turco M, Lansky AJ, Stone GW. Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). The American Journal Of Cardiology 2003, 92: 1095-1098. PMID: 14583363, DOI: 10.1016/j.amjcard.2003.06.006.Peer-Reviewed Original ResearchConceptsSuccessful balloon angioplastyAcute myocardial infarctionBalloon angioplastyRoutine stentingMyocardial infarctionEvent-free survivalPrimary balloon angioplastySuboptimal balloon angioplastyCADILLAC trialUnsuccessful dilatationPrimary interventionAngioplastyStentingInfarctionPatientsDilatationTrialsComparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age
Iakovou I, Dangas G, Mehran R, Mintz GS, Lansky AJ, Aymong ED, Nikolsky E, Vagaonescu T, Glasser LA, Stone GW, Leon MB, Moses JW. Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age. The American Journal Of Cardiology 2003, 92: 1083-1086. PMID: 14583360, DOI: 10.1016/j.amjcard.2003.07.007.Peer-Reviewed Original ResearchClinical implications of myocardial perfusion status assessed by myocardial blush after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial
Costantini C, Lansky A, Shirai K, Cristea E, Brestowski C, Slack S, Fahy M, Grines C, Carroll J, Thomas S, Guagliumi G, Rutherford B, Turco M, Mathias D, Leon M, Stone G. Clinical implications of myocardial perfusion status assessed by myocardial blush after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial. Journal Of The American College Of Cardiology 2003, 41: 391-392. DOI: 10.1016/s0735-1097(03)81126-9.Peer-Reviewed Original ResearchMarked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction
Sadeghi H, Grines C, Mehran R, Dixon S, Lansky A, Fahy M, Cox D, Garcia E, Tcheng J, Griffin J, Guagliumi G, Stuckey T, Turco M, Carroll J, Rutherford B, Stone G. Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Journal Of The American College Of Cardiology 2003, 41: 384. DOI: 10.1016/s0735-1097(03)81097-5.Peer-Reviewed Original ResearchPredictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial
Turco M, Fahy M, Mehran R, Lansky A, Grines C, Tcheng J, Garcia E, Guagliumi G, Cox D, Stuckey T, Shaddinger D, Stone G. Predictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial. Journal Of The American College Of Cardiology 2003, 41: 376. DOI: 10.1016/s0735-1097(03)81064-1.Peer-Reviewed Original ResearchST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial
McLaughlin M, Gardner G, Aymong E, Mehran R, Lansky A, Grines C, Tcheng J, Cox D, Stuckey T, Garcia E, Guagliumi G, Turco M, Zimetbaum P, Stone G. ST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial. Journal Of The American College Of Cardiology 2003, 41: 392. DOI: 10.1016/s0735-1097(03)81128-2.Peer-Reviewed Original Research
2002
Different mechanism of lumen enlargement in lesions with stent underexpansion after balloon angioplasty for in-stent restenosis compared to those with optimal stent expansion: an intravascular ultrasound study
Arif F, Kobayashi Y, Hirose M, Balan O, Reyes A, Iakovou I, Adamian M, Mehran R, Dangas G, Lansky A, Moussa I, Stone G, Leon M, Moses J, Mintz G. Different mechanism of lumen enlargement in lesions with stent underexpansion after balloon angioplasty for in-stent restenosis compared to those with optimal stent expansion: an intravascular ultrasound study. Journal Of The American College Of Cardiology 2002, 39: 36. DOI: 10.1016/s0735-1097(02)80156-5.Peer-Reviewed Original Research
2001
Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results
Hong M, Mehran R, Dangas G, Mintz G, Lansky A, Kent K, Pichard A, Satler L, Stone G, Leon M. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. Journal Of The American College Of Cardiology 2001, 38: 150-154. PMID: 11451265, DOI: 10.1016/s0735-1097(01)01324-9.Peer-Reviewed Original ResearchConceptsLate cardiac eventsSVG lesionsCardiac eventsDistal embolizationStent useSaphenous vein graft angioplastyUnfavorable lesion characteristicsVein graft angioplastyOne-year outcomesProcedural success rateHigh procedural successHigh-risk lesionsGraft angioplastySVG angioplastyLate mortalityRepeat revascularizationBaseline characteristicsProcedural successRisk lesionsFavorable outcomeLesion characteristicsGraft treatmentMultivariate analysisAngioplastyLesions